Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Asparaginase Erwinia chrysanthemi
Trade Name Erwinaze
Synonyms Crisantaspase
Drug Descriptions

Erwinaze (asparaginase Erwinia chrysanthemi) is an bacterial derived enzyme that converts L-asparagine to L-aspartate and ammonia, which decreases L-asparagine levels, potentially leading to reduced leukemic cell growth (PMID: 25098829, PMID: 26698391). Erwinaze (asparaginase Erwinia chrysanthemi) is FDA-approved for use in a chemotherapeutic regimen for acute lymphoblastic leukemia (FDA.gov).

CAS Registry Number 9015-68-3
NCIT ID C64260


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Asparaginase Erwinia chrysanthemi Asparaginase Erwinia chrysanthemi 0 1
Asparaginase Erwinia chrysanthemi + Cytarabine Asparaginase Erwinia chrysanthemi Cytarabine 0 1
Asparaginase Erwinia chrysanthemi + Cytarabine + Sorafenib Asparaginase Erwinia chrysanthemi Cytarabine Sorafenib 0 1

Additional content available in CKB BOOST